— Know what they know.
Not Investment Advice
Also trades as: YCBD-PA (AMEX) · $vol 0M

YCBD AMEX

cbdMD, Inc.
1W: -2.6% 1M: -8.8% 3M: -36.0% YTD: -60.7% 1Y: -60.0% 3Y: -94.6% 5Y: -99.9%
$0.46
+0.01 (+1.22%)
 
Weekly Expected Move ±11.3%
$0 $0 $0 $1 $1
AMEX · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Strong Sell · Power 22 · $4.8M mcap · 10M float · 3.57% daily turnover · Short 23% of daily vol

Cash Flow Trends

Operating Cash Flow
-$1M -311.7% ▼
Capital Expenditures
$184K +36.5% ▲
5Y CAGR: -32.6%
Free Cash Flow
-$2M -154.6% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$191K -129.2% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$23M-$70M-$23M-$4M-$2.0B
Depreciation & Amort.$2M$3M$3M$2M$1.1B
Stock-Based Comp.$3M$929K$343K$17K$0
Change in Working Capital-$3M-$3M$570K-$539K-$2M
Other Non-Cash Items$7M$54M$15M$2M$915M
Operating Cash Flow-$14M-$15M-$4M-$353K-$1M
— Investing Activities —
Capital Expenditures-$2M-$689K-$298K-$290K-$184M
Acquisitions (Net)$2M$0$0$0$0
Investment Purchases-$750K$0$0$0$0
Investment Sales$540K$0$1M$0$0
Other Investing-$2M$0$0$0$184M
Investing Cash Flow-$3M-$689K$702K-$290K-$184K
— Financing Activities —
Net Debt Issuance-$152K-$33K-$133K$1M$0
Stock Repurchased-$31M$0$0$0$0
Dividends Paid-$3M-$4M-$4M$0$0
Other Financing$0$0$0$0$0
Financing Cash Flow$28M-$4M-$1M$1M$1M
Net Change in Cash$12M-$20M-$5M$655K-$191K
Cash End of Period$26M$7M$2M$2M$2M
Free Cash Flow-$16M-$16M-$5M-$643K-$2M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms